The Unexpected Cost of Beating Cancer (Part 2)

This illustrates the challenges that diligent physicians have in keeping up with new developments in their field.

Yesterday, I posted on the side effects of immunotherapy treatment for cancer.

Today, we have an article from researchers at UPenn on the use of an existing drug (a class of drugs known as JAK inhibitors) to reduce the risk of these side effects.

Some doctors use combinations of immunotherapy drugs to assure effectiveness against the target cancer.  However, the combinations seem to increase the risk of major side effects.

Use of the JAK inhibitor with a single immunotherapy drug can be as effective as use of the combination of drugs, without the increased risk of side effects.

Each day, there’s something new.  Is your doctor keeping up with his homework?

That’s the major reason you always need second opinions for anything important.





Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s